Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study

Updated systematic review and meta-analysis of randomized controlled trials comparing low- versus high-dose rituximab for rheumatoid arthritis

(2015) Markus Bredemeier et al.   CLINICAL RHEUMATOLOGY

Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability

(2015) Hélène Zéphir et al.   JOURNAL OF NEUROLOGY

Analysis of the treatment of neuromyelitis optica

(2015) Jose Torres et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Efficacy of rituximab in refractory neuromyelitis optica

(2015) N Collongues et al.   Multiple Sclerosis Journal

Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients

(2015) M Radaelli et al.   Multiple Sclerosis Journal

Challenges and opportunities in designing clinical trials for neuromyelitis optica

(2015) B. G. Weinshenker et al.   NEUROLOGY

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

(2015) Dean M. Wingerchuk et al.   NEUROLOGY

Treatment Outcomes With Rituximab in 100 Patients With Neuromyelitis Optica

(2015) Su-Hyun Kim et al.   JAMA Neurology

Efficacy of rituximab in refractory neuromyelitis optica

(2015) N Collongues et al.   Multiple Sclerosis Journal

Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients

(2015) M Radaelli et al.   Multiple Sclerosis Journal

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate

(2014) Ramnath Santosh Ramanathan et al.   BMC Neurology

Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica

(2014) Maureen A. Mealy et al.   JAMA Neurology

The Pathology of an Autoimmune Astrocytopathy: Lessons Learned from Neuromyelitis Optica

(2013) Claudia F. Lucchinetti et al.   BRAIN PATHOLOGY

Experience with low-dose rituximab in off-label indications at two tertiary hospitals

(2013) J. Chay et al.   INTERNAL MEDICINE JOURNAL

World Medical Association Declaration of Helsinki

(2013)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica

(2013) C.-S. Yang et al.   NEUROLOGY

Low- Versus High-Dose Rituximab for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

(2013) Markus Bredemeier et al.   ARTHRITIS CARE & RESEARCH

A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder

(2013) Su-Hyun Kim et al.   JAMA Neurology

Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients

(2012) Ronald F van Vollenhoven et al.   ANNALS OF THE RHEUMATIC DISEASES

Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: Evolving role of biologic therapies

(2012) Eamonn S. Molloy et al.   ARTHRITIS AND RHEUMATISM

Variable results after rituximab in neuromyelitis optica

(2012) J.W. Lindsey et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Rituximab reduces attacks in Chinese patients with neuromyelitis optica spectrum disorders

(2012) Vincent H.L. Ip et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Efficacy and safety of rituximab therapy for systemic lupus erythematosus: a systematic review and meta-analysis

(2012) Lan Lan et al.   Journal of Zhejiang University-SCIENCE B

Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic success

(2012) Benjamin M Greenberg et al.   Multiple Sclerosis Journal

Treatment of neuromyelitis optica: Review and recommendations

(2012) Dorlan J. Kimbrough et al.   Multiple Sclerosis and Related Disorders

Impact of rituximab on relapse rate and disability in neuromyelitis optica

(2011) Gurdesh S Bedi et al.   Multiple Sclerosis Journal

A Review of Cases of Neuromyelitis Optica

(2011) Roberto Bomprezzi et al.   NEUROLOGIST

Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab

(2011) H. L. Pellkofer et al.   NEUROLOGY

EFNS guidelines on diagnosis and management of neuromyelitis optica

(2010) J. Sellner et al.   EUROPEAN JOURNAL OF NEUROLOGY

Use and monitoring of low dose rituximab in myasthenia gravis

(2010) S. Blum et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Rituximab: Mechanism of Action

(2010) George J. Weiner   SEMINARS IN HEMATOLOGY

Treatment of Neuromyelitis Optica With Rituximab

(2008)   ARCHIVES OF NEUROLOGY

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

(2008) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE